Company News
Deutsche Bank Upgrades Schott Pharma, Target €22
Deutsche Bank raised Schott Pharma rating to Buy from Hold and lifted price target to €22 from €16.
Analyst Falko Friedrichs expects growth acceleration in H2 2026 after first‑half slowdown, citing im
